Results 121 to 130 of about 9,797,826 (264)

Acute intestinal infections in children [PDF]

open access: yes, 2013
Acute intestinal infections - a large group of human infectious diseases caused by pathogenic and opportunistic bacteria, viruses and protozoa. Intestinal infections until now occupy a leading position in infectious diseases, especially in childhood ...
Smiyan, K.O.
core  

Toxin-neutralizing antibodies protect against Clostridium perfringens-induced necrosis in an intestinal loop model for bovine necrohemorrhagic enteritis [PDF]

open access: yes, 2016
Background: Bovine necrohemorrhagic enteritis is caused by Clostridium perfringens type A. Due to the rapid progress and fatal outcome of the disease, vaccination would be of high value. In this study, C.
Deprez, Piet   +10 more
core   +2 more sources

We are not alone: a case for the human microbiome in extra intestinal diseases

open access: yesGut Pathogens, 2017
Background“Dysbiosis” in the gut microbiome has been implicated in auto-immune diseases, in inflammatory diseases, in some cancers and mental disorders.
S. Shivaji
semanticscholar   +1 more source

Heme oxygenase-1 as a modulator of intestinal inflammation development and progression [PDF]

open access: yes, 2018
Indexación: Scopus.Heme Oxygenase 1 (HMOX1) is an enzyme that catalyzes the reaction that degrades the heme group contained in several important proteins, such as hemoglobin, myoglobin, and cytochrome p450.
Alexis M. Kalergis   +12 more
core   +2 more sources

Laminaria japonica Extract Enhances Intestinal Barrier Function by Altering Inflammatory Response and Tight Junction-Related Protein in Lipopolysaccharide-Stimulated Caco-2 Cells. [PDF]

open access: yes, 2019
In the normal physiological state, intestinal epithelial cells act as a defensive frontline of host mucosal immunity to tolerate constant exposure to external stimuli.
Ding   +13 more
core   +1 more source

Early Ustekinumab Use Improves Clinical Outcomes in Biologic-Naive Crohn’s Disease Patients: A Retrospective Multicenter Cohort Study in Taiwan

open access: yesBiomedicines
Background/Objectives: Crohn’s disease (CD) is a progressive condition, and early treatment with infliximab combined with an immunosuppressant within six months has been shown to improve clinical outcomes.
Yen-Cheng Chang   +6 more
doaj   +1 more source

Lnc-ITSN1-2, Derived From RNA Sequencing, Correlates With Increased Disease Risk, Activity and Promotes CD4+ T Cell Activation, Proliferation and Th1/Th17 Cell Differentiation by Serving as a ceRNA for IL-23R via Sponging miR-125a in Inflammatory Bowel Disease

open access: yesFrontiers in Immunology, 2020
Background: This study aimed to investigate long-non-coding RNA (lncRNA) expression profiles and the correlation of lnc-ITSN1-2 expression with disease risk, activity and inflammation, and its influence on CD4+ T cell activation, proliferation, and ...
Jiayan Nie   +3 more
doaj   +1 more source

Helminths as an alternative therapy for intestinal diseases

open access: yesWorld Journal of Gastroenterology, 2017
Animal models and clinical studies have shown that helminth infections exert immunomodulatory activity, altering intestinal permeability and providing a potential beneficial action on autoimmune and inflammatory disorders in human beings, such as ...
A. Sipahi, D. Baptista
semanticscholar   +1 more source

Intestinal Microbiota and Cardiovascular Diseases

open access: yesInternational Journal of Cardiovascular Sciences, 2020
Abstract Recently, gut microbiota has emerged as an important mediator of several diseases such as diabetes, atherosclerosis, arterial hypertension, obesity, cancers and neuropsychiatric diseases including Alzheimer, autism and depression. Intestinal microbiota is formed by bacteria, fungi and viruses and its main function is to facilitate the ...
Protásio L. da Luz   +2 more
openaire   +5 more sources

Use of Thiopurines in Inflammatory Bowel Disease: A Consensus Statement by the Korean Association for the Study of Intestinal Diseases (KASID)

open access: yesIntestinal Research, 2015
Background/Aims For decades, thiopurines have been the mainstay of inflammatory bowel disease (IBD) treatment and will play an important role in the future.
Kang-Moon Lee   +4 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy